Atara Biotherapeutics (ATRA) Research & Development (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Research & Development of $1.35 million for Q2 2026, down 81.6% from $7.31 million a year earlier but up 720.1% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Research & Development (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Atara Biotherapeutics was $4.21 million, down 96.1% year-over-year; for FY2025, it came in at $37.45 million, down 75.3% from FY2024.
- Annual Research & Development has declined for four consecutive years, with a five-year compound annual growth rate of -31.3% (FY2020 to FY2025).
- In prior years, Atara Biotherapeutics' Research & Development was $151.48 million in FY2024 (-32.6%), $224.79 million in FY2023 (-17.5%), $272.53 million in FY2022 (-3.4%) and $282 million in FY2021 (+15.3%).
- Quarterly Research & Development has run from a low of -$223,000 in Q4 2025 to a high of $79.13 million in Q4 2021 over five years.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 20.7%; the weakest was Q1 2026, with a decline of 99.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $164,000 (Q1 2026), -$223,000 (Q4 2025) and $2.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Atara Biotherapeutics | 141.76 Mn | 131.86 Mn | 439,000.00 | 1.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Mn |
| Mar 31, 2026 | 164,000.00 |
| Dec 31, 2025 | -223,000.00 |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 7.31 Mn |
| Mar 31, 2025 | 27.43 Mn |
| Dec 31, 2024 | 28.72 Mn |
| Sep 30, 2024 | 43.92 Mn |
| Jun 30, 2024 | 33.33 Mn |
| Mar 31, 2024 | 45.51 Mn |
| Dec 31, 2023 | 49.60 Mn |
| Sep 30, 2023 | 56.89 Mn |
| Jun 30, 2023 | 56.14 Mn |
| Mar 31, 2023 | 62.16 Mn |
| Dec 31, 2022 | 62.52 Mn |
| Sep 30, 2022 | 70.16 Mn |
| Jun 30, 2022 | 64.90 Mn |
| Mar 31, 2022 | 74.96 Mn |
| Dec 31, 2021 | 79.13 Mn |
| Sep 30, 2021 | 70.33 Mn |
API Access
Atara Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();